Prevalence of isolated antibody to hepatitis B core antigen in an area endemic for hepatitis B virus infection: Implications in hepatitis B vaccination programs

Hepatology

Volumn 8, Issue 4, 1988, Pages 766-770

  Lok, Anna S F ^a   Lai, Ching‐Lung ^a   Wu, Pui‐Chee ^a  

^a UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

[No Author keywords available]

Indexed keywords

HEPATITIS B CORE ANTIBODY; HEPATITIS B CORE ANTIGEN; HEPATITIS B VACCINE;

ADULT; CHRONIC HEPATITIS; CLINICAL ARTICLE; FEMALE; HUMAN; MALE; PRIORITY JOURNAL; VACCINATION;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CHILD; CHILD, PRESCHOOL; FEMALE; HEPATITIS B; HEPATITIS B ANTIBODIES; HEPATITIS B CORE ANTIGENS; HEPATITIS B VACCINES; HUMAN; INFANT; MALE; MIDDLE AGE; SUPPORT, NON-U.S. GOV'T; VACCINATION; VIRAL HEPATITIS VACCINES;

EID: 0023676508     PISSN: 02709139     EISSN: 15273350     Source Type: Journal    
DOI: 10.1002/hep.1840080411     Document Type: Article

References (29)

1. Indications for use of hepatitis B vaccine, based on cost‐effectiveness analysis
2. Antibody to hepatitis B surface antigen and screening before hepatitis B vaccination
3. Screening of health care workers before hepatitis B vaccination: more questions than answers
4. Recommendation of the Immunization Practices Advisory Committee, CDC. Inactivated hepatitis B virus vaccine
5. Occupational exposure to hepatitis B virus in hospital personnel: infection or immunization?
6. Antibodies to hepatitis B surface antigen as the sole hepatitis B marker in hospital personnel
7. Prevalence of anti‐HBc in anti‐HBs positive individuals: implications for selecting vaccine candidates
8. Prevaccination screening of medical and dental students: should low levels of antibody to hepatitis B surface antigen preclude vaccination?
9. Isolated antibody to hepatitis B surface antigen and response to hepatitis B vaccination
10. Epidemiological analysis of the significance of low‐positive test results for antibody to hepatitis B surface and core antigens
11. Contrasting patterns and frequency of antibodies to the surface, core and e antigens of hepatitis B virus in blood donors and homosexual patients
12. Susceptibility to hepatitis B despite high titre anti‐HBs antibody
13. Failure of preexisting antibody against hepatitis B surface antigen to prevent subsequent hepatitis B infection
14. The development of HBsAg‐positive hepatitis despite the previous existence of antibody to HBsAg
15. Serodiagnosis of recent hepatitis B infection by IgM class anti‐HBc
16. State of hepatitis B virus DNA in hepatocytes of patients with hepatitis B surface antigen positive and negative liver disease
17. Hepatitis B vaccine administered to chronic carriers of hepatitis B surface antigen
18. Hepatitis B virus infection in Chinese families in Hong Kong
19. Absence of transmission of hepatitis B by fibreoptic upper gastrointestinal endoscopy
20. An assay for the detection of the DNA genome of hepatitis B virus in serum
21. Hepatitis B virus antibody in blood donors and the occurrence of non‐A, non‐B hepatitis in transfusion recipients: an analysis of the transfusion‐transmitted viruses study
22. Post‐transfusion hepatitis in Australia: report of the Australian Red Cross Study
23. Antibody to hepatitis B core antigen as a paradoxical marker for non‐A, non‐B hepatitis agents in donated blood
24. Non‐A, non‐B hepatitis virus: identification of a core antigen‐antibody system that cross reacts with hepatitis B core antigen and antibody
25. Type B hepatitis after transfusion with blood containing antibody to hepatitis B core antigen
26. Detection and significance of anti‐HBc in the blood bank; preliminary results of a controlled prospective study
27. Anticore antibody screening of transfused blood
28. A review of recent events related to surrogate testing of blood to prevent non‐A, non‐B post‐transfusion hepatitis
29. Hepatitis B core antibody (anti‐HBc) in blood donors in the United States: implications for surrogate testing programs